Up-Regulation of Donor Dendritic Cell PD-L1 Expression Reduced Recipient Lymphocyte Activation and Proliferation...

Area of Science:

• Immunology
• Molecular Biology
• Virology

Background:

• Dendritic cells (DCs) play a crucial role in immune regulation.
• Programmed death-ligand 1 (PD-L1) is a key molecule in immune checkpoint pathways.
• Understanding DC-mediated immune modulation is vital for therapeutic development.

Purpose of the Study:

• To investigate the effect of Ad-PD-L1 transfected dendritic cells on lymphocyte activity.
• To assess the role of PD-1/PD-L1 pathway in T cell proliferation and activation.
• To establish a model for studying immune suppression mediated by engineered DCs.

Main Methods:

• Construction and verification of recombinant adenovirus vector Ad-PD-L1.
• Isolation, culture, and transfection of dendritic cells from C57BL/6 mice.
• Co-culture of transfected DCs with CFSE-labeled lymphocytes from DBA/2 mice.
• Flow cytometry analysis to quantify lymphocyte proliferation and activation.

Main Results:

• Successful construction of Ad-PD-L1 recombinant adenovirus vector.
• Transfection of C57BL/6 DCs with Ad-PD-L1 led to a 37% increase in PD-L1 expression.
• Co-culture resulted in a significant inhibition of DBA/2 lymphocyte proliferation (41%) and activation.

Conclusions:

• The Ad-PD-L1 vector was successfully constructed and validated.
• Transfected DCs expressing PD-L1 effectively suppressed lymphocyte proliferation and activation in recipient mice.
• The PD-1/PD-L1 pathway mediates immune suppression through a costimulatory pathway.